New drug for itchy eyes approved.

The AP (9/9) reported that on Sept. 8, "the Food and Drug Administration approved" Ista Pharmaceuticals, Inc.'s "treatment for itchy eyes in patients with allergic conjunctivitis." Called Bepreve [bepotastine besilate ophthalmic solution], the "eye drops are approved for use by patients" two years of age and older.
According to the Dow Jones Newswire (9/10, Cummings), "Ista said Bepreve and its anti-inflammatory eye drug Xibrom [bromfenac ophthalmic] will share the top spot in the company's promotional activities." Reuters (9/9) and the Orange County Business Journal (9/9, Reed) also covered the story.